What is the Elastography Imaging Market Size?
The global elastography imaging market size was estimated at USD 2.54 billion in 2025 and is predicted to increase from USD 2.73 billion in 2026 to approximately USD 5.19 billion by 2035, expanding at a CAGR of 7.41% from 2026 to 2035. The elastography imaging market is expected to grow due to the increasing prevalence of chronic liver and breast cancer, along with advanced technology in the elastography imaging industry. The market is also expected to grow with the help of artificial intelligence (AI) and machine learning (ML), which aid in automating diagnostic precision by enhancing tissue stiffness and reducing human error.
Market Highlights
- North America dominated the market, holding a share of approximately 36% in 2025.
- Asia Pacific is observed to be the fastest-growing region during the forecast period.
- By modality, the ultrasound elastography segment held the largest elastography imaging market share, accounting for approximately 79% in 2025.
- By modality, the magnetic resonance elastography segment is expected to grow at a remarkable CAGR between 2026 and 2035.
- By technology, the shear wave elastography segment held a major market share of approximately 42% and is expected to be the fastest growing segment between 2026 and 2032.
- By application, the liver disease assessment segment dominated the market with a share of approximately 46% in 2025.
- By application, the prostate imaging segment is expected to grow at the highest CAGR between 2026 and 2035.
- By end-user, the hospitals segment led the elastography imaging market with a share of approximately 47% in 2025
- By end-user, the diagnostic imaging centers segment is expected to show the fastest growth in the forecast period.
- By product type, the elastography-enabled ultrasound systems segment contributed the biggest market share of approximately 58% in 2025.
- By product type, the elastography software/platforms segment is expected to grow swiftly between 2026 and 2035.
- By portability, the cart-based/fixed imaging systems segment held a dominant market share of approximately 71% in 2025.
- By portability, the portable/handheld imaging systems segment is expected to grow rapidly in the foreseen period.
- By clinical workflow, the radiology/imaging department-based use segment accounted for the highest market share of approximately 62 % in 2025.
- By clinical workflow, the point-of-care use (POCUS/bedside) segment is expected to witness the fastest growth in the coming years.
What is Elastography Imaging?
The elastography imaging market comprises diagnostic imaging technologies that measure tissue stiffness/elasticity to support the detection, staging, and monitoring of diseases such as liver fibrosis, tumors, and inflammatory conditions. Elastography is primarily integrated with ultrasound and MRI systems and is widely used in hepatology, radiology, oncology, and women's health.
The market is mainly driven by growing global prevalence of chronic liver diseases and breast cancer. Advanced technologies, coupled with non-invasive and alternative techniques to traditional biopsies, is fueling the market's growth. The technique is also highly preferred by patients and physicians due to its non-invasive characteristics and precise assessment of damaged tissue, allowing for the right treatment procedure to be followed.
What is the Role of AI in the Elastography Imaging Market?
Artificial intelligenceplays a significant role in elastography imaging by introducing automation in complex tissue stiffness analysis, enhancing accuracy, efficiency, and accessibility. AI and ML algorithms analyze vast amounts of patient data and provide assisted classification and prognosis prediction. They also help reduce human error, along with faster detection of fibrosis, cancer, and musculoskeletal conditions. Personalized medication, facilitated by advanced analytics, enables a non-invasive procedure, further supporting the market's growth.
Elastography Imaging Market Trends
AI and Automation- The market is observing growth due to higher usage of AI algorithms along with advanced technology. Advanced technology enables predictive analytics, along with the quantification of tissue stiffness, which is helpful for market growth.
- For instance, In May 2025, a scientific report revealed that early detection of breast cancer with technologically advanced methods helps to enhance diagnostic accuracy and strengthen the reliability of breast cancer detection, improving patient treatment and prognosis.
Expansion of Handheld and Point of Care Devices- Higher usage of handheld shear-wave probes in regions with limited resource facilities is another major factor fueling the market growth.
Increasing Applications in the Healthcare Industry- Elastography imaging is increasingly studied to be used in other domains, apart from breast cancer and liver cirrhosis detection, fueling market growth.
- For instance,In February 2025, a new software release for Philips' EPIQ Elite and AFFIniti ultrasound imaging platforms helps to aid faster workflows and efficient diagnostic processes.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 2.54 Billion |
| Market Size in 2026 | USD 2.73 Billion |
| Market Size by 2035 | USD 5.19 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 7.41% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Modality, Technology Type, Application, End-User, Product Type, Portability, Clinical Workflow, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segmental Insights
Modality Insights
Which Modality Segment Led the Elastography Imaging Market?
The ultrasound elastography segment led the market, accounting for approximately 79% of share in 2025, as it is a low-cost, portable, and real-time imaging method. Factors such as its ease of use, making it ideal for assessing liver disease, breast lesions, and prostate issues, further promotes the use of ultrasound elastography. The rising prevalence of chronic liver diseases and cancer further potentiates the demand for non-invasive treatment methods. Technological advancements in the form of AI and MRI elastography result in higher precision.
The magnetic resonance elastography (MRE) segment is observed to grow rapidly in the foreseen period, as MRE is known for its higher diagnostic accuracy to access deep organs such as the liver, brain, and pancreas. The segment also observes growth as it focuses on providing quantitative data beyond ultrasound's limitations. The segment provides 3D, high-resolution stiffness mapping, offering a superior non-invasive alternative to biopsies.
Technology Insights
How the Shear Wave Elastography Segment Dominated the Elastography Imaging Market?
The shear wave elastography segment dominated the market with a share of approximately 42% in 2025 and is expected to sustain its position in the foreseen period. This segment dominated because of the growing demand for non-invasive imaging techniques. Shear wave elastography can allow the quantification of mechanical and elastic tissue properties. It uses a higher intensity pulse to produce a shear wave.
The strain elastography segment is estimated to be the second-largest growing segment. Strain elastography is a primary tool for differentiating benign and malignant lesions by understanding the tissue stiffness, which increases in the case of later stages of cancer. It is also used to assess tendon and muscle elasticity, providing a low-cost alternative to MRI, which is helpful for sports medicine and physical therapy.
Application Insights
Which Application Segment Dominated the Elastography Imaging Market?
The liver disease assessment segment held the largest market share of approximately 46% in 2025, due to growing chronic liver issues such as fibrosis, fatty liver, and cirrhosis. A huge shift from invasive to non-invasive methods for the treatment of chronic health issues is another major factor fueling the segment's growth. Technological advancement, providing improved resolution, real-time imaging, quantitative analysis, and AI integration, also helps to propel the segment's growth.
The prostate imaging segment is expected to witness the fastest growth between 2026 and 2035. Prostate imaging helps to improve the detection and localization of prostate cancer by mapping tissue stiffness. Prostate cancer is the second leading cause of death in males globally, following lung cancer. Elastography is a non-invasive technique that offers numerous benefits, such as cost-effectiveness and high sensitivity for prostate cancer detection.
End User Insights
Why did the Hospitals Segment Dominate the Elastography Imaging Market?
The hospitals segment contributed the biggest market share of approximately 47% in 2025, due to the presence of a developed infrastructure, higher usage of advanced medical technologies, and high procedure volume for liver fibrosis, cancer, and other similar chronic health issues. Patients prefer technologically advanced non-invasive treatment methods. Hospitals have skilled professionals and favourable reimbursement policies, benefiting patients.
The diagnostic imaging centers segment is expected to expand rapidly in the forecast period. Specialized centers nowadays are adopting non-invasive methods. Diagnostic centers have the suitable capital investment to adopt innovative devices. They facilitate patient referrals and increase utilization. They have trained professionals to operate complex devices and provide personalized care to patients.
Product Type Insights
Which Product Type Segment Dominated the Elastography Imaging Market?
The elastography-enabled ultrasound systems held a dominant market share of approximately 58% in 2025, due to their cost-effectiveness, portability, real-time imaging, and non-invasive nature. Elastography-enabled ultrasound systems help identify chronic issues such as liver cirrhosis, breast lesions, and prostate cancer. A major shift of patients from large hospitals to small clinics with technologically advanced medical aids and imaging facilities is another major factor for the segment's growth.
The elastography software/platforms segment is expected to grow at the highest CAGR over the studied period. Software/platforms focus on advanced processing, AI integration, and user-friendly interfaces like 2D or 3D imaging. Such advancements enhance accuracy, speed, and workflow, thereby smoothing the entire diagnostic procedure. Healthcare professionals can generate reports and observe minute changes within a patient's body through software/platforms.
Portability Insights
How the Cart-Based/Fixed Imaging Systems Segment Led the Elastography Imaging Market?
The cart-based/fixed imaging systems segment contributed the biggest market share of approximately 71% in 2025, due to its higher adoption by hospitals and huge medical centers for the detection of liver fibrosis, musculoskeletal issues, and breast issues. Cart-based/fixed imaging systems are designed for intuitive operation and high performance across all clinical settings. They are particularly useful in inpatient settings, providing real-time patient data.
The portable/handheld imaging systems segment is expected to be the fastest-growing segment in the coming years. This is due to higher demand for point-of-care and non-invasive methods. Portable systems are comparatively cost-effective, efficient, and easy to use, deriving accurate results. They generate rapid results and eliminate the need for a specialized infrastructure for their installation, augmenting the segment's growth.
Clinical Workflow Insights
Which Clinical Workflow Segment Led the Elastography Imaging Market?
The radiology/imaging department-based use segment held a major market share of approximately 62% in 2025, due to high patient volumes, suitable infrastructure, and the presence of skilled professionals. Government and private bodies provide investment to adopt advanced medical devices in the radiology department. Patients have high trust in radiology-based diagnosis, as they provide accurate and precise results with appropriate guidance.
The point-of-care use (POCUS/bedside) segment is expected to account for the highest growth in the coming years. This is due to higher demand for the portable ultrasound system, AI integration, and the versatility of devices to detect major health issues. The easy usage of handheld devices in emergency settings, clinics, and rural areas due to their ease of use also boosts the segment's growth. They can be placed anywhere and eliminate the need for patients to travel between departments in healthcare settings.
Regional Insights
How Big is the North America Elastography Imaging Market Size?
The North Americaelastography imaging market size is estimated at USD 914.40 billion in 2025 and is projected to reach approximately USD 1,894.35 billion by 2035, with a 7.56% CAGR from 2026 to 2035.
Which Factors Drive the Elastography Imaging Market in North America?
North America dominated the market with a share of approximately 36% in 2025, mainly due to factors such as developed medical infrastructure, high chronic disease rates, and the usage of advanced technologies such as MRI and ultrasound. North Americans are increasingly aware of screening and early diagnosis of cancer and other chronic conditions, potentiating the use of elastography imaging. Favorable government initiatives and regulatory policies also foster market growth.
What is the Size of the U.S. Elastography Imaging Market?
The U.S.elastography imaging market size is calculated at USD 685.80 billion in 2025 and is expected to reach nearly USD 1,430.20 billion in 2035, accelerating at a strong CAGR of 7.63% between 2026 and 2035.
U.S. Market Trends
The U.S. is a major contributor to the market due to the presence of a robust healthcare infrastructure, growing R&D, and higher usage of elastography imaging methods in different domains. Rising cases of liver diseases, cancer, and obesity also fuel market growth. It is projected that, by 2050, over 122 million adults will suffer from metabolic dysfunction-associated steatotic liver disease (MASLD).
How Will Asia Pacific Grow in the Elastography Imaging Market?
Asia Pacific is expected to be the fastest-growing region in the foreseen period, due to the growing population, burgeoning healthcare sector, increasing prevalence of chronic diseases, and higher demand for non-invasive treatment options. The region has a suitable manufacturing infrastructure for the domestic manufacturing of elastography machines at affordable costs. Supportive government medical facilities also help treat serious issues at low costs, enhancing accessibility and affordability for the rural population.
China Market Trends
China holds a major share, due to the growing prevalence of chronic issues and government investments. The Chinese government offers discounted loans for the adoption or upgradation of medical devices in hospitals/clinics. Higher healthcare awareness and the rising adoption of advanced technologies also contribute to market growth.
Elastography Imaging Market Value Chain Analysis
- R&D
The R&D focuses on enhancing the diagnostic precision, including AI, and expanding its clinical utility beyond liver disease assessment.
Key Players: GE HealthCare, Philips Healthcare, and Siemens Healthineers.
- Distribution to Hospitals & Clinics
Elastography imaging devices are distributed to hospitals/clinics either directly through manufacturers or distributors and wholesalers.
Key Players: Fujifilm Holdings and Mindray Bio-Medical Electronics.
- Patient Support & Services
Patient support & services refer to guiding patients about benefits of elastography imaging and providing financial assistance.
Recent Developments in the Elastography Imaging Market
- In November 2025, Canon Medical Systems received U.S. Food and Drug Administration (FDA) approval for its ultrasound processing algorithms to enhance image quality, microvascular flow assessment, and elastography performance. The system can extract higher-order harmonic components to improve spatial resolution and reduce noise.(Source: https://radiologybusiness.com)
- In April 2025, Royal Philips, a healthcare technology company, launched the Elevate platform upgrade for its EPIQ Elite ultrasound system. The platform involves the addition of Auto ElastQ for liver elastography, providing a non-invasive method to measure liver stiffness.(Source: https://health.economictimes.indiatimes.com)
Who are the Major Players in the Global Elastography Imaging Market?
The major players in the elastography imaging market include Canon Medical Systems Corporation, Esaote SpA, FUJIFILM Corporation, GE Healthcare, Hitachi, Ltd, Koninklijke Philips N.V., Mindray Bio-Medical Electronics Co., Ltd., Samsung Medison Co., Ltd., Siemens, and Toshiba America Medical Systems, Inc.
Segments Covered in the Report
By Modality
- Ultrasound Elastography
- Strain elastography
- Shear wave elastography
- Transient elastography
- Magnetic Resonance Elastography
By Technology Type
- Shear Wave Elastography
- Strain Elastography
- Transient Elastography
- Other Elastography Technologies
By Application
- Liver Disease Assessment
- Breast Imaging
- Thyroid Imaging
- Prostate Imaging
- Musculoskeletal Imaging
- Other Applications
By End-User
- Hospitals
- Diagnostic Imaging Centers
- Specialty Clinics
- Research & Academic Institutes
By Product Type
- Elastography-Enabled Ultrasound Systems
- Elastography Software/Platforms
- MRI Elastography Systems/Add-on Modules
- Accessories & Consumables
By Portability
- Cart-based/Fixed Imaging Systems
- Portable/Handheld Imaging Systems
By Clinical Workflow
- Radiology/Imaging Department-based Use
- Point-of-Care Use (POCUS/bedside)
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Get a Sample
Table Of Content